Greenleaf Trust Moderna, Inc. Transaction History

Greenleaf Trust

$10.7 Billion
Q1 2024

A detailed history of Greenleaf Trust transactions in Moderna, Inc. stock. As of the latest transaction made, Greenleaf Trust holds 3,253 shares of MRNA stock, worth $377,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,253

Previous 2,300 41.43%

Holding current value

$377,185

Previous $228,000 51.75%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$85.37 - $115.44 $81,357 - $110,014	953 Added 41.43%	3,253 $346,000
Q4 2023 Jan 31, 2024	SELL	$69.51 - $104.43 $33,712 - $50,648	-485 Reduced 17.41%	2,300 $228,000
Q3 2023 Nov 09, 2023	SELL	$96.41 - $126.61 $29,597 - $38,869	-307 Reduced 9.93%	2,785 $287,000
Q2 2023 Aug 09, 2023	SELL	$118.5 - $160.53 $50,362 - $68,225	-425 Reduced 12.08%	3,092 $375,000
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $209,866 - $304,789	-1,547 Reduced 30.55%	3,517 $540,000

Q4 2022 Jan 25, 2023	BUY	$118.38 - $210.04 $266,473 - $472,800	2,251 Added 80.02%	5,064 $910,000
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $25,621 - $42,137	-217 Reduced 7.16%	2,813 $333,000
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $13,001 - $19,601	111 Added 3.8%	3,030 $433,000
Q1 2022 Apr 27, 2022	BUY	$126.46 - $235.05 $24,280 - $45,129	192 Added 7.04%	2,919 $503,000
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $167,332 - $273,065	-741 Reduced 21.37%	2,727 $693,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $769,549 - $1.68 Million	3,468 New	3,468 $1.34 Million

Others Institutions Holding MRNA

# of Institutions

1,038

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.

Account